On-time enrollment in pivotal Phase 2 & 3 clinical trials
> 90% repeat and referral rate for clients
Extensive and diverse team of experts across 60+ countries
How does it happen?
We meet deadlines and enrollment milestones, time and time and time again. In fact, you could say our obsession with timelines is something of an unfair advantage. We’ve built a name by coming to the rescue when trials fall behind and sponsors have to start from scratch. “We Can Do Hard Things” is one of our rallying cries, and it’s true.
On-time delivery goes hand in hand with world class service. In an industry where being behind schedule is considered par for the course, we dare to buck the trend. It’s time to choose the CRO you can trust.
Ready to push your trial ahead?
Here are 3 simple first steps on the way to a successful trial:
Don’t put up with poor performance. For 25 years PSI has built such trusted relationships with biotech sponsors, that 90% of our customers are repeat and referral.
Save Time
We know that the industry is riddled with delays. In fact, 90% of trials aren’t on schedule. But at PSI, we deliver on-time, over and over again. In fact, we’re even known to enroll ahead of time.
Save Money
Your product is important, and your team has the potential to change lives for patients all around the world. Save money by choosing the right CRO from the beginning. Our budgets are tried and true, and we’ll be on-target the entire time.
Save Reputation
We deliver quality, and we deliver on-time. Our teams work tirelessly to ensure your study, and the reputation of your product will speak volumes.
Our latest case studies
The PSI Advantage
For the sixth year in a row, PSI CRO has been named a CRO Leadership Award winner in the categories of Expertise, Quality, and Reliability in the Overall (combined Big and Small pharma) respondent group. The CRO Leadership Awards are presented by Life Sciences Leader and Clinical Leader based on research conducted by ISR Reports. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.
